Reply to Skowronski, De Serres, and Orenstein

Affiliations

¹ Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
² Kaiser Permanente Washington Health Research Institute, Seattle.
³ School of Public Health, Curtin University, Perth, Australia.
⁴ Chief Physician's Office, Clalit Health Services, Clalit Research Institute, Tel Aviv, Israel.
⁵ Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
⁶ Abt Associates, Cambridge, Massachusetts.
⁷ Cumming School of Medicine, University of Calgary, Alberta, Canada.
⁸ Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland.
⁹ Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon.

Comment

Mark G Thompson et al. Clin Infect Dis. 2019.

. 2019 Aug 30;69(6):1085-1086.

doi: 10.1093/cid/ciz115.

¹ Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
² Kaiser Permanente Washington Health Research Institute, Seattle.
³ School of Public Health, Curtin University, Perth, Australia.
⁴ Chief Physician's Office, Clalit Health Services, Clalit Research Institute, Tel Aviv, Israel.
⁵ Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
⁶ Abt Associates, Cambridge, Massachusetts.
⁷ Cumming School of Medicine, University of Calgary, Alberta, Canada.
⁸ Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland.
⁹ Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon.

No abstract available

Comment on

Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: A Multi-country Retrospective Test Negative Design Study, 2010-2016.
Thompson MG, Kwong JC, Regan AK, Katz MA, Drews SJ, Azziz-Baumgartner E, Klein NP, Chung H, Effler PV, Feldman BS, Simmonds K, Wyant BE, Dawood FS, Jackson ML, Fell DB, Levy A, Barda N, Svenson LW, Fink RV, Ball SW, Naleway A; PREVENT Workgroup. Thompson MG, et al. Clin Infect Dis. 2019 Apr 24;68(9):1444-1453. doi: 10.1093/cid/ciy737. Clin Infect Dis. 2019. PMID: 30307490
Caution Required in the Use of Administrative Data and General Laboratory Submissions for Influenza Vaccine Effectiveness Estimation.
Skowronski DM, De Serres G, Orenstein WA. Skowronski DM, et al. Clin Infect Dis. 2019 Aug 30;69(6):1084-1085. doi: 10.1093/cid/ciz113. Clin Infect Dis. 2019. PMID: 30753442 Free PMC article. No abstract available.

Assessment of the benefits of seasonal influenza vaccination: Elements of a framework to interpret estimates of vaccine effectiveness and support robust decision-making and communication.
Hollingsworth R, El Guerche-Séblain C, Tsai T, Vasiliev Y, Lee S, Bright H, Barbosa P. Hollingsworth R, et al. Influenza Other Respir Viruses. 2021 Jan;15(1):164-174. doi: 10.1111/irv.12786. Epub 2020 Sep 3. Influenza Other Respir Viruses. 2021. PMID: 32885610 Free PMC article. Review.